C-reactive protein is a risk indicator for atrial fibrillation after myocardial revascularization

Bernard Lo1, Rob Fijnheer, Arno P Nierich

  • 1Department of Anesthesiology, University Medical Center Utrecht, Utrecht, The Netherlands. b.lo@azu.nl

Insights

High baseline C-reactive protein (CRP) levels indicate a greater risk for postoperative atrial fibrillation (AF) after coronary artery bypass graft surgery. This risk applies to both on-pump and off-pump procedures.

Area of Science:

  • Cardiology
  • Inflammation Research
  • Surgical Outcomes

Background:

  • Coronary artery bypass graft (CABG) surgery activates the complement system, involving C-reactive protein (CRP).
  • Elevated baseline CRP levels correlate with increased risk of postoperative atrial fibrillation (AF).
  • The study examines if baseline CRP predicts AF and if cardiopulmonary bypass influences this association.

Purpose of the Study:

  • To determine if baseline C-reactive protein (CRP) levels predict the occurrence of postoperative atrial fibrillation (AF).
  • To assess whether the association between CRP and AF is dependent on the use of cardiopulmonary bypass during CABG surgery.

Main Methods:

  • Measured perioperative C-reactive protein (CRP) in patients undergoing CABG surgery, with or without cardiopulmonary bypass (Octopus Study).
  • Categorized baseline CRP into low (<3.0 mg/L) and high (≥3.0 mg/L) groups.
  • Analyzed AF incidence based on baseline CRP levels and surgical method (on-pump vs. off-pump).

Main Results:

  • In on-pump CABG, high baseline CRP was linked to significantly higher AF rates (55%) compared to low CRP (21%, p=0.01).
  • In off-pump CABG, high baseline CRP also showed a higher AF incidence (30%) versus low CRP (8%, p=0.002).
  • Adjusted analysis confirmed baseline CRP as an independent predictor of AF across both surgical groups (OR=3.3, p=0.02).

Conclusions:

  • Elevated baseline C-reactive protein (CRP) levels are a significant risk factor for developing postoperative atrial fibrillation (AF).
  • This increased risk associated with high CRP is evident regardless of whether cardiopulmonary bypass is used during coronary artery bypass graft surgery.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...